Login

Corline Biomedical - Naventus Healthcare Summit, May 10, 2022 - Henrik Nittmar, CEO at Corline Biomedical 00:00:00

Share On Facebook Share On Twitter

Corline Biomedical - Naventus Healthcare Summit, May 10, 2022

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Christopher Gallen on Building a Biotech Business in Asia | Christopher Gallen, President, SK Biopharmaceuticals, Korea.
00:10:00
Basel III: A Critical Look at Banking Reform and Risk | Insights from Wharton Experts
00:10:00
Ryan Long Discusses Copper Fox Metals' Strategy and Key Assets with Katie
00:10:00
British technology entrepreneur and investor|Josh Buckley,Managing Director,Buckley Ventures
00:10:00
Gary Leung and Ronnie Ho: Spearheading Tactical Multi-Strategy Investing at East Eagle Asset Management
00:10:00
Steven van Rijswijk, CEO of ING, discusses global business and market trends in an interview with CNBC at the World Economic Forum.
00:10:00
K92 Mining Expands Production and Resource Base with New Phases and Significant Investments
00:10:00
Analyzing Market Opportunities: Insights into the Foord Equity Fund | Cobie Legrange - Fundamental Analyst, Acsis
00:10:00
Scott Morris, presidente e CEO da Avista, representou a empresa como Parceira do Ano no Red Tie Gala de 2018.
00:10:00
Rainbow Rare Earths' Expansion Plans and Market Outlook at One-to-One Mining Conference, Cape Town
00:10:00
Why Startups Innovate Faster than Internet Giants|Hurst lin,General Partner, DCM
00:10:00
Night Ventures helps founders navigate new forms of customer acquisition|Reed Duchscher,General Partner,Night Ventures

© 2017 - Neuhu+